Biotech Growth N V - 21 Oct 2022 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role: 10%+ Owner
Signature: /s/Ivo Betschart
Issuer symbol: BDTX
Transactions as of: 21 Oct 2022
Transactions value $: $132,750
Form type: 4
Filing time: 25 Oct 2022, 16:24:30 UTC
Previous filing: 21 Oct 2022
Next filing: 28 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDTX	Common Stock	Purchase	$133K	+87.9K	+1.82%	$1.51	4.91M	21 Oct 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Black Diamond Therapeutics, Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.